Survival Analysis of Our Patients Diagnosed with Testicular Cancer
Ozlem Nuray Sever1, Mehmet Solakhan2, Tahir Yerlikaya3, Serkan Enki3, Mustafa Yýildiz3, Mustafa Yildirim11Department of Medical Oncology, Sanko University, Gaziantep, Turkey, 2Department of Urology, Gaziantep Medicalpark Hospital, Gaziantep, Turkey, 3Department of Medical Oncology, SBU Antalya Training and Research Hospital, Antalya, Turkey
Objective: The aim of our study is to determine the relationship between clinicopathological parameters and survival in our patients with testicular cancer who were followed up and treated in our centers. Materials and Methods: Patients who were followed up and treated with the diagnosis of testicular cancer in Antalya Training and Research Hospital and Sanko University Hospital Medical Oncology Clinics were evaluated retrospectively. Results: 164 patients with a mean age of 32.8±10.8 (range 15.6-67) years were included in the study. Seminoma was detected in 68 (41.5%) patients, non-seminomatous germ cell tumor (NSGCT) was detected in 91 (55.5%) patients, and non-germ cell testicular carcinoma was detected in 5 (3%) patients. A statistically significant difference was found between histological type and age (p<0.001). Mean age was 37.4±10.1 (range 20-67) years in seminoma patients, 28.4±8.6 (range 15.6-52.14) years in NSGCT patients, 53.6±9.6 (range 41.2-62.8) years in non-germ cell testicular cancers. A statistically significant difference was found between histological subtype and stage (p=0.003). Of the patients diagnosed with seminoma, 54 (85.7%) patients were stage I, 6 (9.5%) patients were stage II, and 3 (4.8%) patients were stage III. In the NSGCT group, 47 (54.7%) patients were stage I, 17 (19.8%) patients were stage II, 22 (25.6%) patients were stage III. Stage I disease was detected in all patients diagnosed with non-germ cell testicular tumor. Discussion: Testicular cancer is the most common solid tumor seen in men aged 20-34 years. NSGCTs are diagnosed at a more advanced stage compared to seminomas. Keywords: Testicular Cancer, Histological Subtype, Survival
Cite This Article
Sever O, Solakhan M, Yerlikaya T, Enki S, Yýildiz M, Yildirim M. Survival Analysis of Our Patients Diagnosed with Testicular Cancer. EJMI. 2022; 6(2): 176-179
Corresponding Author: Ozlem Nuray Sever